A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease.

Seung-Hyun Baek, Suji Hong, Eunae Kim, Sunyoung Park, Minyoung Lee, Jinsu Park, Yoonsuk Cho, Hyunjun Yoon, Daeseung Kim, Youngkwang Yun, Youbin Kim, Yoonjung Choi, Keunsoo Kang, Sangyong Jung, Jun Pyo Kim, Eunha Kim, Sang Won Seo, Yong-Keun Jung, Dong-Gyu Jo
Author Information
  1. Seung-Hyun Baek: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  2. Suji Hong: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  3. Eunae Kim: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  4. Sunyoung Park: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  5. Minyoung Lee: Department of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
  6. Jinsu Park: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  7. Yoonsuk Cho: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  8. Hyunjun Yoon: Deargen Inc., Daejeon, 34051, Republic of Korea.
  9. Daeseung Kim: Deargen Inc., Daejeon, 34051, Republic of Korea.
  10. Youngkwang Yun: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
  11. Youbin Kim: School of Biological Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  12. Yoonjung Choi: Deargen Inc., Daejeon, 34051, Republic of Korea.
  13. Keunsoo Kang: Deargen Inc., Daejeon, 34051, Republic of Korea.
  14. Sangyong Jung: Department of Medical Science, College of Medicine, CHA University, Seongnam, 13496, Republic of Korea.
  15. Jun Pyo Kim: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06355, Republic of Korea.
  16. Eunha Kim: Department of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
  17. Sang Won Seo: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06355, Republic of Korea.
  18. Yong-Keun Jung: School of Biological Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  19. Dong-Gyu Jo: School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea. ORCID

Abstract

β-secretase (BACE1) is instrumental in amyloid-β (Aβ) production, with overexpression noted in Alzheimer's disease (AD) neuropathology. The interaction of Aβ with the receptor for advanced glycation endproducts (RAGE) facilitates cerebral uptake of Aβ and exacerbates its neurotoxicity and neuroinflammation, further augmenting BACE1 expression. Given the limitations of previous BACE1 inhibition efforts, the study explores reducing BACE1 expression to mitigate AD pathology. The research reveals that the anticancer agent 6-thioguanosine (6-TG) markedly diminishes BACE1 expression without eliciting cytotoxicity while enhancing microglial phagocytic activity, and ameliorate cognitive impairments with reducing Aβ accumulation in AD mice. Leveraging advanced deep learning-based tool for target identification, and corroborating with surface plasmon resonance assays, it is elucidated that 6-TG directly interacts with RAGE, modulating BACE1 expression through the JAK2-STAT1 pathway and elevating soluble RAGE (sRAGE) levels in the brain. The findings illuminate the therapeutic potential of 6-TG in ameliorating AD manifestations and advocate for small molecule strategies to increase brain sRAGE levels, offering a strategic alternative to the challenges posed by the complexity of AD.

Keywords

References

  1. a) J. Wang, B. J. Gu, C. L. Masters, Y. J. Wang, Nat. Rev. Neurol. 2017, 13, 612;
  2. b) H. Lee, D. Kim, W. Lee, H. Y. Kim, Y. Kim, Arch. Pharm. Res. 2019, 42, 647.
  3. G. S. Bloom, JAMA Neurol. 2014, 71, 505.
  4. S. H. Baek, S. J. Park, J. I. Jeong, S. H. Kim, J. Han, J. W. Kyung, S. H. Baik, Y. Choi, B. Y. Choi, J. S. Park, G. Bahn, J. H. Shin, D. S. Jo, J. Y. Lee, C. G. Jang, T. V. Arumugam, J. Kim, J. W. Han, J. Y. Koh, D. H. Cho, D. G. Jo, J. Neurosci. 2017, 37, 5099.
  5. A. Serrano‐Pozo, S. Das, B. T. Hyman, Lancet Neurol. 2021, 20, 68.
  6. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, C. Cruchaga, C. Sassi, J. S. Kauwe, S. Younkin, L. Hazrati, J. Collinge, J. Pocock, T. Lashley, J. Williams, J. C. Lambert, P. Amouyel, A. Goate, R. Rademakers, K. Morgan, J. Powell, P. St George‐Hyslop, A. Singleton, J. Hardy, N. Engl. J. Med. 2013, 368, 117.
  7. D. A. Butterfield, B. Halliwell, Nat. Rev. Neurosci. 2019, 20, 148.
  8. J. Park, H. J. Ha, E. S. Chung, S. H. Baek, Y. Cho, H. K. Kim, J. Han, J. H. Sul, J. Lee, E. Kim, J. Kim, Y. R. Yang, M. Park, S. H. Kim, T. V. Arumugam, H. Jang, S. W. Seo, P. G. Suh, D. G. Jo, Sci. Adv. 2021, 7, eabd3207.
  9. M. A. DeTure, D. W. Dickson, Mol. Neurodegener. 2019, 14, 32.
  10. H. W. Querfurth, F. M. LaFerla, N. Engl. J. Med. 2010, 362, 329.
  11. I. C. Stancu, B. Vasconcelos, D. Terwel, I. Dewachter, Mol. Neurodegener. 2014, 9, 51.
  12. Y. Cho, H. G. Bae, E. Okun, T. V. Arumugam, D. G. Jo, Pharmacol. Ther. 2022, 235, 108122.
  13. H. Hampel, R. Vassar, B. De Strooper, J. Hardy, M. Willem, N. Singh, J. Zhou, R. Yan, E. Vanmechelen, A. De Vos, R. Nisticò, M. Corbo, B. P. Imbimbo, J. Streffer, I. Voytyuk, M. Timmers, A. A. Tahami Monfared, M. Irizarry, B. Albala, A. Koyama, N. Watanabe, T. Kimura, L. Yarenis, S. Lista, L. Kramer, A. Vergallo, Biol. Psychiatry 2021, 89, 745.
  14. A. R. Gwon, J. S. Park, T. V. Arumugam, Y. K. Kwon, S. L. Chan, S. H. Kim, S. H. Baik, S. Yang, Y. K. Yun, Y. Choi, S. Kim, S. C. Tang, D. H. Hyun, A. Cheng, C. E. Dann, 3rd, M. Bernier, J. Lee, W. R. Markesbery, M. P. Mattson, D. G. Jo, Aging Cell 2012, 11, 559.
  15. a) Y. Li, W. Zhou, Y. Tong, G. He, W. Song, FASEB J. 2006, 20, 285;
  16. b) G. Bahn, J. S. Park, U. J. Yun, Y. J. Lee, Y. Choi, J. S. Park, S. H. Baek, B. Y. Choi, Y. S. Cho, H. K. Kim, J. Han, J. H. Sul, S. H. Baik, J. Lim, N. Wakabayashi, S. H. Bae, J. W. Han, T. V. Arumugam, M. P. Mattson, D. G. Jo, Proc. Natl. Acad. Sci. 2019, 116, 12516.
  17. a) N. M. Moussa‐Pacha, S. M. Abdin, H. A. Omar, H. Alniss, T. H. Al‐Tel, Med. Res. Rev. 2020, 40, 339;
  18. b) M. Hrabinova, J. Pejchal, T. Kucera, D. Jun, M. Schmidt, O. Soukup, Curr. Neuropharmacol. 2021, 19, 61.
  19. a) M. Dierich, S. Hartmann, N. Dietrich, P. Moeser, F. Brede, L. J. Chacko, K. Tziridis, A. Schilling, P. Krauss, S. Hessler, S. Karch, A. Schrott‐Fischer, M. Blumer, C. Birchmeier, D. Oliver, T. Moser, H. Schulze, C. Alzheimer, M. G. Leitner, T. Huth, J. Neurosci. 2019, 39, 9013;
  20. b) B. Das, N. Singh, A. Y. Yao, J. Zhou, W. He, X. Hu, R. Yan, Mol. Psych. 2021, 26, 2694;
  21. c) M. H. Ou‐Yang, J. E. Kurz, T. Nomura, J. Popovic, T. W. Rajapaksha, H. Dong, A. Contractor, D. M. Chetkovich, W. G. Tourtellotte, R. Vassar, Sci. Transl. Med. 2018, 10, eaao5620.
  22. a) X. Hu, J. Hu, L. Dai, B. Trapp, R. Yan, J. Neurosci. 2015, 35, 3806;
  23. b) D. Dominguez, J. Tournoy, D. Hartmann, T. Huth, K. Cryns, S. Deforce, L. Serneels, I. E. Camacho, E. Marjaux, K. Craessaerts, A. J. Roebroek, M. Schwake, R. D'Hooge, P. Bach, U. Kalinke, D. Moechars, C. Alzheimer, K. Reiss, P. Saftig, B. De Strooper, J. Biol. Chem. 2005, 280, 30797;
  24. c) F. M. Laird, H. Cai, A. V. Savonenko, M. H. Farah, K. He, T. Melnikova, H. Wen, H. C. Chiang, G. Xu, V. E. Koliatsos, D. R. Borchelt, D. L. Price, H. K. Lee, P. C. Wong, J. Neurosci. 2005, 25, 11693.
  25. a) B. V. Zlokovic, Nat. Rev. Neurosci. 2011, 12, 723;
  26. b) S. D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, A. M. Schmidt, Nature 1996, 382, 685;
  27. c) S. F. Yan, R. Ramasamy, A. M. Schmidt, Circ. Res. 2010, 106, 842;
  28. d) E. Sturchler, A. Galichet, M. Weibel, E. Leclerc, C. W. Heizmann, J. Neurosci. 2008, 28, 5149.
  29. R. Deane, S. Du Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A. M. Schmidt, D. L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, B. Zlokovic, Nat. Med. 2003, 9, 907.
  30. K. Takuma, F. Fang, W. Zhang, S. Yan, E. Fukuzaki, H. Du, A. Sosunov, G. McKhann, Y. Funatsu, N. Nakamichi, T. Nagai, H. Mizoguchi, D. Ibi, O. Hori, S. Ogawa, D. M. Stern, K. Yamada, S. S. Yan, Proc. Natl. Acad. Sci. USA 2009, 106, 20021.
  31. S. D. Yan, S. F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M. A. Smith, G. Perry, G. C. Godman, P. Nawroth, J. L. Zweier, D. Stern, Nat. Med. 1995, 1, 693.
  32. a) H. J. Cho, S. M. Son, S. M. Jin, H. S. Hong, D. H. Shin, S. J. Kim, K. Huh, I. Mook‐Jung, FASEB J. 2009, 23, 2639;
  33. b) M. Guglielmotto, M. Aragno, E. Tamagno, I. Vercellinatto, S. Visentin, C. Medana, M. G. Catalano, M. A. Smith, G. Perry, O. Danni, G. Boccuzzi, M. Tabaton, Neurobiol. Aging 2012, 33, 196.
  34. K. N. Z. Fuller, E. R. Miranda, J. P. Thyfault, J. K. Morris, J. M. Haus, Mediators Inflamm. 2018, 2018, 2061376.
  35. a) Z. Cai, N. Liu, C. Wang, B. Qin, Y. Zhou, M. Xiao, L. Chang, L. J. Yan, B. Zhao, Cell. Mol. Neurobiol. 2016, 36, 483;
  36. b) R. Ghidoni, L. Benussi, M. Glionna, M. Franzoni, D. Geroldi, E. Emanuele, G. Binetti, J. Neural. Transm. 2008, 115, 1047.
  37. S. Gunnarsdottir, A. A. Elfarra, Drug Metab. Dispos. 2003, 31, 718.
  38. a) N. T. Vethe, S. Bremer, S. Bergan, Scand. J. Clin. Lab. Invest. 2008, 68, 277;
  39. b) J. W. Weiss, H. C. Pitot, Cancer Res. 1974, 34, 581;
  40. c) C. R. Flowers, K. L. Melmon, Nat. Med. 1997, 3, 136.
  41. a) S. L. Cole, R. Vassar, Mol. Neurodegener. 2007, 2, 22;
  42. b) X. Hu, B. Das, H. Hou, W. He, R. Yan, J. Exp. Med. 2018, 215, 927.
  43. B. Shin, S. Park, K. Kang, J. C. Ho, Proceedings of the 4th Machine Learning for Healthcare Conference, Proceedings of Machine Learning Research, 2019, https://doi.org/10.48550/arXiv.1908.06760.
  44. a) H. J. Cho, S. M. Jin, S. M. Son, Y. W. Kim, J. Y. Hwang, H. S. Hong, I. Mook‐Jung, Biochem. Biophys. Res. Commun. 2009, 386, 175;
  45. b) M. Jain, M. K. Singh, H. Shyam, A. Mishra, S. Kumar, A. Kumar, J. Kushwaha, Ann. Neurosci. 2021, 28, 191;
  46. c) M. Rusek, J. Smith, K. El‐Khatib, K. Aikins, S. J. Czuczwar, R. Pluta, Int. J. Mol. Sci. 2023, https://doi.org/10.3390/ijms24010864.
  47. a) R. Vassar, Alzheimers Res. Ther. 2014, 6, 89;
  48. b) R. Vassar, B. D. Bennett, S. Babu‐Khan, S. Kahn, E. A. Mendiaz, P. Denis, D. B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M. A. Jarosinski, A. L. Biere, E. Curran, T. Burgess, J. C. Louis, F. Collins, J. Treanor, G. Rogers, M. Citron, Science 1999, 286, 735.
  49. M. E. Kennedy, A. W. Stamford, X. Chen, K. Cox, J. N. Cumming, M. F. Dockendorf, M. Egan, L. Ereshefsky, R. A. Hodgson, L. A. Hyde, S. Jhee, H. J. Kleijn, R. Kuvelkar, W. Li, B. A. Mattson, H. Mei, J. Palcza, J. D. Scott, M. Tanen, M. D. Troyer, J. L. Tseng, J. A. Stone, E. M. Parker, M. S. Forman, Sci. Transl. Med. 2016, 8, 363ra150.
  50. K. Sakamoto, S. Matsuki, K. Matsuguma, T. Yoshihara, N. Uchida, F. Azuma, M. Russell, G. Hughes, S. B. Haeberlein, R. C. Alexander, S. Eketjall, A. R. Kugler, J. Clin. Pharmacol. 2017, 57, 1460.
  51. a) N. Hawkes, BMJ 2017, 356, j845;
  52. b) S. Villarreal, F. Zhao, L. A. Hyde, D. Holder, T. Forest, M. Sondey, X. Chen, C. Sur, E. M. Parker, M. E. Kennedy, J. Alzheimers Dis. 2017, 59, 1393.
  53. M. L. Hemming, J. E. Elias, S. P. Gygi, D. J. Selkoe, PLoS One 2009, 4, e8477.
  54. L. Stertz, V. Contreras‐Shannon, N. Monroy‐Jaramillo, J. Sun, C. Walss‐Bass, Mol. Neurobiol. 2018, 55, 709.
  55. D. K. Lahiri, B. Maloney, J. M. Long, N. H. Greig, Alzheimers Dement. 2014, 10, S411.
  56. D. T. Coulson, N. Beyer, J. G. Quinn, S. Brockbank, J. Hellemans, G. B. Irvine, R. Ravid, J. A. Johnston, J. Alzheimers Dis. 2010, 22, 1111.
  57. a) H. Wang, L. Song, F. Laird, P. C. Wong, H. K. Lee, J. Neurosci. 2008, 28, 8677;
  58. b) M. Willem, A. N. Garratt, B. Novak, M. Citron, S. Kaufmann, A. Rittger, B. DeStrooper, P. Saftig, C. Birchmeier, C. Haass, Science 2006, 314, 664;
  59. c) H. Hou, Q. Fan, W. He, H. Suh, X. Hu, R. Yan, Stem Cell Rep. 2017, 9, 217.
  60. S. Moreno, M. Fickl, I. Bauer, M. Brunner, A. Rázková, D. Rieder, I. Delazer, R. Micura, A. Lusser, J. Med. Chem. 2022, 65, 15165.
  61. P. Karran, N. Attard, Nat. Rev. Cancer 2008, 8, 24.
  62. a) M. M. Safar, N. N. Shahin, A. F. Mohamed, N. F. Abdelkader, Chem. Biol. Interact. 2020, 328, 109144;
  63. b) C. Y. Wang, J. W. Xie, Y. Xu, T. Wang, J. H. Cai, X. Wang, B. L. Zhao, L. An, Z. Y. Wang, Antioxid. Redox Signal. 2013, 19, 2024.
  64. P. Zhu, M. Ren, C. Yang, Y. X. Hu, J. M. Ran, L. Yan, Exp. Dermatol. 2012, 21, 123.
  65. a) P. Millot, C. San, E. Bennana, B. Porte, N. Vignal, J. Hugon, C. Paquet, B. Hosten, F. Mouton‐Liger, Immunol. Lett. 2020, 228, 129;
  66. b) L. Chami, F. Checler, Mol. Neurodegener. 2012, 7, 52.
  67. V. V. Metz, E. Kojro, D. Rat, R. Postina, PLoS One 2012, 7, e41823.
  68. a) A. H. Burstein, M. Sabbagh, R. Andrews, C. Valcarce, I. Dunn, L. Altstiel, J. Prev. Alzheimers Dis. 2018, 5, 149;
  69. b) R. Deane, I. Singh, A. P. Sagare, R. D. Bell, N. T. Ross, B. LaRue, R. Love, S. Perry, N. Paquette, R. J. Deane, M. Thiyagarajan, T. Zarcone, G. Fritz, A. E. Friedman, B. L. Miller, B. V. Zlokovic, J. Clin. Invest. 2012, 122, 1377.
  70. a) H. Singh, D. K. Agrawal, Drug Dev. Res. 2022, 83, 1257;
  71. b) A. Bierhaus, P. M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D. M. Stern, P. P. Nawroth, J. Mol. Med. 2005, 83, 876;
  72. c) S. S. Leung, D. J. Borg, D. A. McCarthy, T. E. Boursalian, J. Cracraft, A. Zhuang, A. K. Fotheringham, N. Flemming, T. Watkins, J. J. Miles, P. H. Groop, J. L. Scheijen, C. G. Schalkwijk, R. J. Steptoe, K. J. Radford, M. Knip, J. M. Forbes, Diabetes 2022, 71, 1994.
  73. S. H. Baek, Y. Cho, J. Lee, B. Y. Choi, Y. Choi, J. S. Park, H. Kim, J. Sul, E. Kim, J. H. Park, D. G. Jo, Bio. Protoc. 2018, 8, e2871.
  74. G. M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, W. Sherman, J. Comput. Aided. Mol. Des. 2013, 27, 221.
  75. Y. Kim, B. Shin, in Proceedings of the 6th Machine Learning for Healthcare Conference, Proceedings of Machine Learning Research, Cambridge, MA 2021, pp. 1–16.
  76. a) R. A. Friesner, J. L. Banks, R. B. Murphy, T. A. Halgren, J. J. Klicic, D. T. Mainz, M. P. Repasky, E. H. Knoll, M. Shelley, J. K. Perry, D. E. Shaw, P. Francis, P. S. Shenkin, J. Med. Chem. 2004, 47, 1739;
  77. b) T. A. Halgren, R. B. Murphy, R. A. Friesner, H. S. Beard, L. L. Frye, W. T. Pollard, J. L. Banks, J. Med. Chem. 2004, 47, 1750.

Grants

  1. NRF-2022R1I1A1A01072791/National Research Foundation of Korea
  2. RS-2019-NR040057/National Research Foundation of Korea
  3. RS-2024-00399237/National Research Foundation of Korea
  4. RS-2024-00345742/National Research Foundation of Korea
  5. RS-2021-KS211513/Ministry of Oceans and Fisheries' R&D project, Korea
  6. No. SMX1240561/Future Medicine 20*30 Project of Samsung Medical Center

Word Cloud

Created with Highcharts 10.0.0BACE1ADRAGEexpressionAlzheimer's6-TGdiseaseadvancedreducingdeepsRAGElevelsbrainβ-secretaseinstrumentalamyloid-βproductionoverexpressionnotedneuropathologyinteractionreceptorglycationendproductsfacilitatescerebraluptakeexacerbatesneurotoxicityneuroinflammationaugmentingGivenlimitationspreviousinhibitioneffortsstudyexploresmitigatepathologyresearchrevealsanticanceragent6-thioguanosinemarkedlydiminisheswithoutelicitingcytotoxicityenhancingmicroglialphagocyticactivityamelioratecognitiveimpairmentsaccumulationmiceLeveraginglearning-basedtooltargetidentificationcorroboratingsurfaceplasmonresonanceassayselucidateddirectlyinteractsmodulatingJAK2-STAT1pathwayelevatingsolublefindingsilluminatetherapeuticpotentialamelioratingmanifestationsadvocatesmallmoleculestrategiesincreaseofferingstrategicalternativechallengesposedcomplexityNovelModulatorInducesSolubleReduceExpressionDisease6‐Thioguanosine6‐TGamyloid‐βlearningdrugrepurposing

Similar Articles

Cited By